SU1429031A1
(ru)
|
1986-06-20 |
1988-10-07 |
Калининский Государственный Медицинский Институт |
Способ дифференциальной диагностики гломерулонефрита и пиелонефрита
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
US5939272A
(en)
|
1989-01-10 |
1999-08-17 |
Biosite Diagnostics Incorporated |
Non-competitive threshold ligand-receptor assays
|
US5028535A
(en)
|
1989-01-10 |
1991-07-02 |
Biosite Diagnostics, Inc. |
Threshold ligand-receptor assay
|
US5922615A
(en)
|
1990-03-12 |
1999-07-13 |
Biosite Diagnostics Incorporated |
Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
|
JPH05504841A
(ja)
|
1990-09-14 |
1993-07-22 |
バイオサイト・ダイアグノスティックス・インコーポレイテッド |
リガンドレセプター及びリガンドのコンプレックスに対する抗体及びリガンド―レセプターアッセーでのそれらの用途
|
US5955377A
(en)
|
1991-02-11 |
1999-09-21 |
Biostar, Inc. |
Methods and kits for the amplification of thin film based assays
|
EP0585310B1
(de)
|
1991-04-10 |
1999-03-17 |
Biosite Diagnostics Inc. |
"crosstalk"- oder übersprech-inhibitoren und ihre verwendung
|
JP3290988B2
(ja)
|
1991-04-11 |
2002-06-10 |
バイオサイト・ダイアグノスティックス・インコーポレイテッド |
多重リガンドを同時検出する新規接合体及び検定法
|
US5885527A
(en)
|
1992-05-21 |
1999-03-23 |
Biosite Diagnostics, Inc. |
Diagnostic devices and apparatus for the controlled movement of reagents without membrances
|
US6143576A
(en)
|
1992-05-21 |
2000-11-07 |
Biosite Diagnostics, Inc. |
Non-porous diagnostic devices for the controlled movement of reagents
|
US5494829A
(en)
|
1992-07-31 |
1996-02-27 |
Biostar, Inc. |
Devices and methods for detection of an analyte based upon light interference
|
US5824799A
(en)
|
1993-09-24 |
1998-10-20 |
Biosite Diagnostics Incorporated |
Hybrid phthalocyanine derivatives and their uses
|
US6498142B1
(en)
|
1996-05-06 |
2002-12-24 |
Curis, Inc. |
Morphogen treatment for chronic renal failure
|
CA2257851C
(en)
|
1996-05-24 |
2011-11-15 |
Biogen, Inc. |
Modulators of tissue regeneration
|
US5753455A
(en)
|
1996-09-03 |
1998-05-19 |
Bayer Corporation |
Method for the detection of lysozyme using a protein error indicator dye in conjunction with an alkane sulfonic acid
|
US6113855A
(en)
|
1996-11-15 |
2000-09-05 |
Biosite Diagnostics, Inc. |
Devices comprising multiple capillarity inducing surfaces
|
US5947124A
(en)
|
1997-03-11 |
1999-09-07 |
Biosite Diagnostics Incorporated |
Diagnostic for determining the time of a heart attack
|
US6057098A
(en)
|
1997-04-04 |
2000-05-02 |
Biosite Diagnostics, Inc. |
Polyvalent display libraries
|
EP0984984A2
(de)
|
1997-06-03 |
2000-03-15 |
Sagami Chemical Research Center |
Menschliche proteine mit transmembrandomänen und dns, die für diese kodieren
|
US20060223077A1
(en)
|
1997-06-06 |
2006-10-05 |
Human Genome Sciences, Inc. |
207 human secreted proteins
|
US6218122B1
(en)
|
1998-06-19 |
2001-04-17 |
Rosetta Inpharmatics, Inc. |
Methods of monitoring disease states and therapies using gene expression profiles
|
US6958147B1
(en)
|
1998-10-26 |
2005-10-25 |
Licentia Ltd |
Use of VEGF-C to prevent restenosis
|
ATE376187T1
(de)
|
1998-12-21 |
2007-11-15 |
Univ Monash |
Nachweis von erkrankungen der nieren und behandlung
|
RU2180965C1
(ru)
|
2000-07-03 |
2002-03-27 |
Габбасова Наталья Вадимовна |
Способ дифференциальной диагностики заболеваний почек
|
EP1405072A2
(de)
|
2000-12-29 |
2004-04-07 |
Oxford GlycoSciences (UK) Limited |
Proteine, gene und ihre verwendungen zur diagnose und behandlung von nierenkrankheiten
|
US20060088823A1
(en)
|
2001-03-29 |
2006-04-27 |
Brian Haab |
Microarray gene expression profiling in clear cell renal cell carcinoma : prognosis and drug target identification
|
US20070015146A1
(en)
|
2001-05-22 |
2007-01-18 |
Gene Logic, Inc. |
Molecular nephrotoxicology modeling
|
US7235358B2
(en)
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
US20030003588A1
(en)
|
2001-06-28 |
2003-01-02 |
Comper Wayne D. |
Method for kidney disease detection by protein profiling
|
JP2006508014A
(ja)
|
2001-07-24 |
2006-03-09 |
イエール・ユニバーシテイ |
キチナーゼおよびキチナーゼ様分子、ならびに炎症性疾患に関する方法、組成物およびキット
|
US6784154B2
(en)
|
2001-11-01 |
2004-08-31 |
University Of Utah Research Foundation |
Method of use of erythropoietin to treat ischemic acute renal failure
|
US8404229B2
(en)
|
2001-12-07 |
2013-03-26 |
Cytori Therapeutics, Inc. |
Methods of using adipose derived stem cells to treat acute tubular necrosis
|
GB0130557D0
(en)
|
2001-12-20 |
2002-02-06 |
Serono Internat S A |
Proteins
|
AU2003219275B2
(en)
|
2002-03-07 |
2008-01-24 |
Cambridge Enterprise Ltd |
SCD fingerprints
|
EP1532268A4
(de)
|
2002-03-21 |
2006-07-05 |
Yissum Res Dev Co |
Zur diagnose von multipler sklerose geeignete periphere blutzellenmarker sowie diese nutzende verfahren und kits
|
US7138230B2
(en)
|
2002-12-06 |
2006-11-21 |
Renovar, Inc. |
Systems and methods for characterizing kidney diseases
|
US7138229B2
(en)
|
2002-12-06 |
2006-11-21 |
Renovar, Inc. |
Systems and methods for characterizing kidney diseases
|
WO2004005934A2
(en)
|
2002-07-04 |
2004-01-15 |
Oxford Glycosciences (Uk) Ltd |
Toxicity markers
|
US6941172B2
(en)
|
2002-11-18 |
2005-09-06 |
Zvi Nachum |
Method and device for restoring kidney function using electromagnetic stimulation
|
US20060063156A1
(en)
|
2002-12-06 |
2006-03-23 |
Willman Cheryl L |
Outcome prediction and risk classification in childhood leukemia
|
CN1791797A
(zh)
|
2003-03-27 |
2006-06-21 |
儿童医院医疗中心 |
用于检测肾小管细胞损伤的早发的方法和试剂盒
|
AU2004229501B2
(en)
|
2003-04-11 |
2011-08-18 |
Medimmune, Llc |
Recombinant IL-9 antibodies and uses thereof
|
WO2005002416A2
(en)
|
2003-06-04 |
2005-01-13 |
Joslin Diabetes Center, Inc. |
Predictors of renal disease
|
US20050148029A1
(en)
|
2003-09-29 |
2005-07-07 |
Biosite, Inc. |
Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
|
GB0329288D0
(en)
|
2003-12-18 |
2004-01-21 |
Inverness Medical Switzerland |
Monitoring method and apparatus
|
US20070280930A1
(en)
|
2004-03-17 |
2007-12-06 |
Kasper Mathias Antoon Rouschop |
Cd44-Targeting for Reducing/Preventing Ischemia-Reperfusion-Injury
|
BRPI0510266A
(pt)
|
2004-04-26 |
2007-10-30 |
Childrens Medical Center |
métodos para a detecção de uma doença ou distúrbio angiogênico em um indivìduo, para a detecção de cáncer em um indivìduo, para o tratamento de um indivìduo afetado com uma doença ou distúrbio angiogênico, para a determinação da probabilidade de eficácia de uma terapia anti-angiogênica, para a determinação da eficácia de uma terapia de teste na modulação dos nìveis de reguladores angiogênicos de plaqueta, para a criação de um registro ou perfil de plaqueta para uma doença ou distúrbio angiogênico e para a monitoração da eficácia de uma terapia em um indivìduo com uma doença ou distúrbio angiogênico
|
US20050272101A1
(en)
|
2004-06-07 |
2005-12-08 |
Prasad Devarajan |
Method for the early detection of renal injury
|
US7588892B2
(en)
|
2004-07-19 |
2009-09-15 |
Entelos, Inc. |
Reagent sets and gene signatures for renal tubule injury
|
US20080038192A1
(en)
|
2004-07-19 |
2008-02-14 |
Neurochem Inc. |
Diagnostic Methods Of Multiple Organ Amyloidosis
|
US7141382B1
(en)
|
2004-10-12 |
2006-11-28 |
Parikh Chirag R |
Methods for detection of IL-18 as an early marker for diagnosis of acute renal failure and predictor of mortality
|
AU2006210837B2
(en)
|
2005-01-31 |
2012-07-12 |
Genentech, Inc. |
Anti-EphB2 antibodies and methods using same
|
WO2006083986A2
(en)
*
|
2005-02-01 |
2006-08-10 |
Government Of The U.S.A, As Represented By The Secretary Department Of Health & Human Services |
Biomarkers for tissue status
|
US20060205625A1
(en)
|
2005-02-18 |
2006-09-14 |
Solvay Pharmaceuticals Gmbh |
Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics
|
JP2008537875A
(ja)
|
2005-03-14 |
2008-10-02 |
ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ |
固形臓器移植レシピエントにおいて移植片生着を評価するための方法および組成物
|
US7608413B1
(en)
|
2005-03-25 |
2009-10-27 |
Celera Corporation |
Kidney disease targets and uses thereof
|
US20070037232A1
(en)
|
2005-03-31 |
2007-02-15 |
Barasch Jonathan M |
Detection of NGAL in chronic renal disease
|
EP1877559B1
(de)
|
2005-04-18 |
2010-10-13 |
Mitomics Inc. |
Mitochondriale mutationen und umlagerungen als diagnostisches werkzeug zum nachweis von sonneneinstrahlung, prostatakrebs und anderen krebserkrankungen
|
US20070087387A1
(en)
|
2005-04-21 |
2007-04-19 |
Prasad Devarajan |
Method for the Early Detection of Renal Disease Using Proteomics
|
WO2007013919A2
(en)
|
2005-07-21 |
2007-02-01 |
The Johns Hopkins University |
Methods of detecting and treating acute kidney injury
|
US7759077B2
(en)
|
2005-08-02 |
2010-07-20 |
Shariat Shahrokh F |
Soluble fas urinary marker for the detection of bladder transitional cell carcinoma
|
EP1757940A1
(de)
|
2005-08-26 |
2007-02-28 |
Cézanne S.A.S. |
In vitro Methode zur Diagnose und zum Monitoring von Nierenzellkarzinom unter Verwendung von MMP-7 als humoraler Biomarker für Nierenzellkarzinom
|
JP2009510478A
(ja)
|
2005-10-03 |
2009-03-12 |
バイオサイト インコーポレイテッド |
全身性炎症反応症候群の診断および/または予後診断のための方法および組成物
|
US20080090304A1
(en)
|
2006-10-13 |
2008-04-17 |
Barasch Jonathan Matthew |
Diagnosis and monitoring of chronic renal disease using ngal
|
US8329408B2
(en)
|
2005-10-31 |
2012-12-11 |
Bayer Healthcare Llc |
Methods for prognosis and monitoring cancer therapy
|
US10716749B2
(en)
|
2005-11-03 |
2020-07-21 |
Palo Alto Investors |
Methods and compositions for treating a renal disease condition in a subject
|
WO2007054975A1
(en)
|
2005-11-08 |
2007-05-18 |
Panacea Biotec Ltd |
Pharmaceutical compositions for the treatment of cardiovascular and other associated disorders
|
US20080133141A1
(en)
|
2005-12-22 |
2008-06-05 |
Frost Stephen J |
Weighted Scoring Methods and Use Thereof in Screening
|
TW200726845A
(en)
|
2006-01-02 |
2007-07-16 |
Nat Defense Medical Ct |
Biomarker molecular of renal illness and detecting method for the same
|
GB0605217D0
(en)
|
2006-03-15 |
2006-04-26 |
Novartis Ag |
Method and compositions for assessing acute rejection
|
GB0606776D0
(en)
|
2006-04-03 |
2006-05-10 |
Novartis Pharma Ag |
Predictive biomarkers for chronic allograft nephropathy
|
US7662578B2
(en)
*
|
2006-04-21 |
2010-02-16 |
Children's Hospital Medical Center |
Method and kit for the early detection of impaired renal status
|
US20070278989A1
(en)
|
2006-05-17 |
2007-12-06 |
Jay Leboff |
Power supply with solar charged battery
|
US20080038269A1
(en)
|
2006-05-25 |
2008-02-14 |
Mount Sinai Hospital |
Methods for detecting and treating kidney disease
|
WO2008084331A2
(en)
|
2006-06-21 |
2008-07-17 |
Hopitaux Universitaires De Geneve |
Biomarkers for renal disorders
|
WO2008005375A2
(en)
|
2006-06-30 |
2008-01-10 |
Merck & Co., Inc. |
Kidney toxicity biomarkers
|
EP2049713A4
(de)
|
2006-07-21 |
2010-06-16 |
Univ Alberta |
Gewebeabstossung
|
GB0617429D0
(en)
|
2006-09-05 |
2006-10-18 |
Electrophoretics Ltd |
Markers of renal transplant rejection and renal damage
|
US20080206794A1
(en)
|
2006-09-15 |
2008-08-28 |
Renovar Incorporated |
Systems And Methods For Characterizing Contrast Induced-Nephropathy
|
US7842472B2
(en)
|
2006-11-14 |
2010-11-30 |
Alere International |
Methods and compositions for monitoring and risk prediction in cardiorenal syndrome
|
WO2008073899A2
(en)
|
2006-12-08 |
2008-06-19 |
The Children's Hospital Of Philadelphia |
Prrg4-associated compositions and methods of use thereof in methods of tumor diagnosis
|
GB0701626D0
(en)
|
2007-01-22 |
2007-03-07 |
Cambridge Entpr Ltd |
Methods and biomarkers for diagnosing and monitoring psychotic disorders
|
WO2008104803A2
(en)
|
2007-02-26 |
2008-09-04 |
Oxford Genome Sciences (Uk) Limited |
Proteins
|
US8221995B2
(en)
|
2007-03-23 |
2012-07-17 |
Seok-Won Lee |
Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
|
EP2479568B1
(de)
|
2007-03-26 |
2015-01-07 |
Novartis AG |
Prognostische Biomarker der renalen Sicherheit und Biomarker-Signatur zur Überwachung der Nierenfunktion
|
CA2682538A1
(en)
|
2007-04-10 |
2008-10-16 |
Integragen |
Human diabetes susceptibility tnfrsf10b gene
|
US8080394B2
(en)
|
2007-04-27 |
2011-12-20 |
Brigham And Women's Hospital |
Method for determining predisposition to pulmonary infection
|
WO2008150488A1
(en)
|
2007-06-01 |
2008-12-11 |
Laboratory Corporation Of America Holdings |
Methods and systems for quantification of peptides and other analytes
|
US20100184110A1
(en)
*
|
2007-06-06 |
2010-07-22 |
Siemens Healthcare Diagnostics Inc. |
Predictive diagnostics for kidney disease
|
US20090047689A1
(en)
|
2007-06-20 |
2009-02-19 |
John Kolman |
Autoantigen biomarkers for early diagnosis of lung adenocarcinoma
|
US20100267041A1
(en)
|
2007-09-14 |
2010-10-21 |
Predictive Biosciences, Inc. |
Serial analysis of biomarkers for disease diagnosis
|
WO2009038742A2
(en)
|
2007-09-20 |
2009-03-26 |
Caritas St. Elizabeth's Medical Center Of Boston, Inc. |
Method for estimating risk of acute kidney injury
|
US8039227B2
(en)
|
2007-09-20 |
2011-10-18 |
University Of Louisville Research Foundation, Inc. |
Peptide biomarkers predictive of renal function decline and kidney disease
|
US8003333B2
(en)
|
2007-09-28 |
2011-08-23 |
Mayo Foundation For Medical Education And Research |
Serum biomarkers for early detection of acute cellular rejection
|
CA2716854A1
(en)
|
2008-02-29 |
2009-09-03 |
National University Corporation Nagoya University |
Biomarker for the estimation of acute renal disorder and prognosis of the disorder, and use of the biomarker
|
US20090298106A1
(en)
|
2008-05-30 |
2009-12-03 |
Therapeutic Monitoring Services, L.L.C. |
Methods for Monitoring Immunosuppressant Drug Levels, Renal Function, and Hepatic Function Using Small Volume Samples
|
US8241861B1
(en)
|
2008-07-08 |
2012-08-14 |
Insilicos, Llc |
Methods and compositions for diagnosis or prognosis of cardiovascular disease
|
EP2149613A1
(de)
|
2008-07-28 |
2010-02-03 |
Greenwood Genetic Center, Inc. |
Verfahren zur Bestimmung der Dysregulierung der Methylation von hirnexprimierten Genen auf dem X-Chromosom zur Diagnose von autistischen Spektrumsstörungen
|
US8673574B2
(en)
|
2008-08-21 |
2014-03-18 |
Pxbiosciences Llc |
Diagnosis and monitoring of renal failure using peptide biomarkers
|
MX341926B
(es)
|
2008-08-28 |
2016-09-07 |
Astute Medical Inc |
Metodos y composiciones para la diagnosis y prognosis de daño renal y falla renal.
|
EP2813848A3
(de)
|
2008-08-29 |
2015-03-11 |
Astute Medical, Inc. |
Verfahren und Zusammensetzungen zur Diagnose und Prognose von Nierenläsion und Niereninsuffizienz
|
US8501489B2
(en)
|
2008-09-26 |
2013-08-06 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Urinary biomarkers to predict long-term dialysis
|
NZ592358A
(en)
|
2008-10-21 |
2013-05-31 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure using tissue inhibitor of metalloproteinase 2 (timp-2)
|
WO2010048347A2
(en)
|
2008-10-21 |
2010-04-29 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
KR20110084286A
(ko)
|
2008-11-10 |
2011-07-21 |
아스튜트 메디컬 인코포레이티드 |
신손상 및 신부전의 진단 및 예후 예측을 위한 방법 및 조성물
|
NZ601575A
(en)
|
2009-02-06 |
2014-08-29 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and failure
|
US9229010B2
(en)
|
2009-02-06 |
2016-01-05 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
WO2010111746A1
(en)
|
2009-04-03 |
2010-10-07 |
Vegenics Limited |
Anti-vegf-d antibodies
|
EP2427494B1
(de)
|
2009-05-08 |
2017-10-18 |
Novartis AG |
Methoden zur modulation von fibrose mittels bmp-9 modulatoren
|
CA2770266A1
(en)
|
2009-08-07 |
2011-02-10 |
Rules-Based Medicine, Inc. |
Methods and devices for detecting kidney damage
|
AU2010295287B2
(en)
|
2009-09-21 |
2014-09-04 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
CA2784889C
(en)
|
2009-12-20 |
2018-06-19 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
US20130035290A1
(en)
|
2011-05-17 |
2013-02-07 |
Yale University |
Chitinase-3-Like Protein 1 as a Biomarker of Recovery from Kidney Injury
|